242 related articles for article (PubMed ID: 20519885)
1. Mastocytosis.
Brockow K; Metcalfe DD
Chem Immunol Allergy; 2010; 95():110-124. PubMed ID: 20519885
[TBL] [Abstract][Full Text] [Related]
2. Assessing anaphylactic risk? Consider mast cell clonality.
Metcalfe DD; Schwartz LB
J Allergy Clin Immunol; 2009 Mar; 123(3):687-8. PubMed ID: 19281912
[No Abstract] [Full Text] [Related]
3. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L
J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Expression of Mast Cell Activation Disorders.
Broesby-Olsen S; Carter M; Kjaer HF; Mortz CG; Møller MB; Kristensen TK; Bindslev-Jensen C; Agertoft L
Immunol Allergy Clin North Am; 2018 Aug; 38(3):365-377. PubMed ID: 30007457
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in mastocytosis research. Summary of the Vienna Mastocytosis Meeting 1998.
Valent P; Escribano L; Parwaresch RM; Schemmel V; Schwartz LB; Sotlar K; Sperr WR; Horny HP
Int Arch Allergy Immunol; 1999 Sep; 120(1):1-7. PubMed ID: 10529583
[TBL] [Abstract][Full Text] [Related]
6. The Role of KIT Mutations in Anaphylaxis.
Coulson E; Zhou S; Akin C
Curr Allergy Asthma Rep; 2019 Apr; 19(6):31. PubMed ID: 31028494
[TBL] [Abstract][Full Text] [Related]
7. Mastocytosis: immunophenotypical features of the transformed mast cells are unique among hematopoietic cells.
Horny HP; Sotlar K; Valent P
Immunol Allergy Clin North Am; 2014 May; 34(2):315-21. PubMed ID: 24745676
[TBL] [Abstract][Full Text] [Related]
8. The presence of mast cell clonality in patients with unexplained anaphylaxis.
Gülen T; Hägglund H; Sander B; Dahlén B; Nilsson G
Clin Exp Allergy; 2014 Sep; 44(9):1179-87. PubMed ID: 25039926
[TBL] [Abstract][Full Text] [Related]
9. Anaphylaxis and mast cell disease: what is the risk?
Akin C
Curr Allergy Asthma Rep; 2010 Jan; 10(1):34-8. PubMed ID: 20425512
[TBL] [Abstract][Full Text] [Related]
10. New Insights into Clonal Mast Cell Disorders Including Mastocytosis.
Volertas S; Schuler CF; Akin C
Immunol Allergy Clin North Am; 2018 Aug; 38(3):341-350. PubMed ID: 30007455
[TBL] [Abstract][Full Text] [Related]
11. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
12. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
Bonadonna P; Perbellini O; Passalacqua G; Caruso B; Colarossi S; Dal Fior D; Castellani L; Bonetto C; Frattini F; Dama A; Martinelli G; Chilosi M; Senna G; Pizzolo G; Zanotti R
J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713
[TBL] [Abstract][Full Text] [Related]
13. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
Divekar R; Butterfield J
Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
[TBL] [Abstract][Full Text] [Related]
14. Anaphylaxis with clonal mast cells in normal looking skin - a new entity?
Bretterklieber A; Beham-Schmid C; Sturm GJ; Berghold A; Brezinschek R; Aberer W; Aberer E
Allergy; 2015 Jul; 70(7):864-72. PubMed ID: 25899109
[TBL] [Abstract][Full Text] [Related]
15. Pathology of extramedullary mastocytosis.
Doyle LA; Hornick JL
Immunol Allergy Clin North Am; 2014 May; 34(2):323-39. PubMed ID: 24745677
[TBL] [Abstract][Full Text] [Related]
16. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.
Picard M; Giavina-Bianchi P; Mezzano V; Castells M
Clin Ther; 2013 May; 35(5):548-62. PubMed ID: 23642289
[TBL] [Abstract][Full Text] [Related]
17. [Tryptase: A practical guide for the physician].
Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S
Rev Med Interne; 2020 Nov; 41(11):748-755. PubMed ID: 32712042
[TBL] [Abstract][Full Text] [Related]
18. A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis.
Carter MC; Desai A; Komarow HD; Bai Y; Clayton ST; Clark AS; Ruiz-Esteves KN; Long LM; Cantave D; Wilson TM; Scott LM; Simakova O; Jung MY; Hahn J; Maric I; Metcalfe DD
J Allergy Clin Immunol; 2018 Jan; 141(1):180-188.e3. PubMed ID: 28629749
[TBL] [Abstract][Full Text] [Related]
19. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.
Longley BJ; Tyrrell L; Lu SZ; Ma YS; Langley K; Ding TG; Duffy T; Jacobs P; Tang LH; Modlin I
Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724
[TBL] [Abstract][Full Text] [Related]
20. The transcriptome of the human mast cell leukemia cells HMC-1.2: an approach to identify specific changes in the gene expression profile in KitD816V systemic mastocytosis.
Haenisch B; Herms S; Molderings GJ
Immunol Res; 2013 May; 56(1):155-62. PubMed ID: 23504229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]